These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
275 related articles for article (PubMed ID: 34468015)
1. miR‑32‑5p suppresses the proliferation and migration of pancreatic adenocarcinoma cells by targeting TLDC1. Yuan P; Tang C; Chen B; Lei P; Song J; Xin G; Wang Z; Hui Y; Yao W; Wang G; Zhao G Mol Med Rep; 2021 Nov; 24(5):. PubMed ID: 34468015 [TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA PITPNA‑AS1 silencing suppresses proliferation, metastasis and epithelial‑mesenchymal transition in non‑small cell lung cancer cells by targeting microRNA‑32‑5p. Chen G; Zheng Z; Li J; Zhang P; Wang Z; Guo S; Ma J; Shen J; Li H Mol Med Rep; 2021 Mar; 23(3):. PubMed ID: 33495838 [TBL] [Abstract][Full Text] [Related]
3. CircRNA PGAM1 Promotes the Migration and Invasion of Pancreatic Adenocarcinoma Cells by Activating the AKT/mTOR Signaling Pathway. Wang F; Yan X; Peng X; Liu D; Bu W; Kang F; Song J; Wang Q Mol Biotechnol; 2024 Sep; 66(9):2341-2348. PubMed ID: 37702882 [TBL] [Abstract][Full Text] [Related]
4. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression. Li T; Zhao H; Zhou H; Geng T PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995 [TBL] [Abstract][Full Text] [Related]
5. Unraveling the role of Major Vault Protein as a novel immune-related biomarker that promotes the proliferation and migration in pancreatic adenocarcinoma. Wu X; Hao L; Lin J; Guo X; Luo Y; Li C Front Immunol; 2024; 15():1399222. PubMed ID: 39026679 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis. Cheng J; Lou Y; Jiang K Bioengineered; 2021 Dec; 12(1):96-107. PubMed ID: 33345740 [TBL] [Abstract][Full Text] [Related]
7. LINC00941 promotes proliferation and metastasis of pancreatic adenocarcinoma by competitively binding miR-873-3p and thus upregulates ATXN2. Fang L; Wang SH; Cui YG; Huang L Eur Rev Med Pharmacol Sci; 2021 Feb; 25(4):1861-1868. PubMed ID: 33660796 [TBL] [Abstract][Full Text] [Related]
8. LncRNA MBNL1-AS1 Suppresses Cell Proliferation and Metastasis of Pancreatic Adenocarcinoma through Targeting Carcinogenic miR-301b-3p. Sulidankazha C; Alidake ; Lin H; He T; Han W; Chen Q Genet Res (Camb); 2023; 2023():6785005. PubMed ID: 36908851 [TBL] [Abstract][Full Text] [Related]
9. FUBP1 mediates the growth and metastasis through TGFβ/Smad signaling in pancreatic adenocarcinoma. Zhang Y; Chen J; Zhou N; Lu Y; Lu J; Xing X; Chen H; Zhang X Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33649780 [TBL] [Abstract][Full Text] [Related]
10. Clinicopathological Characteristics, Prognosis, and Correlated Tumor Cell Function of Tropomodulin-3 in Pancreatic Adenocarcinoma. Zhong B; Ma DD; Zhang T; Gong Q; Dong Y; Zhang JX; Li ZH; Jin WD Comb Chem High Throughput Screen; 2024; 27(7):1011-1021. PubMed ID: 37563820 [TBL] [Abstract][Full Text] [Related]
11. Integrated bioinformatics analysis identifies PCSK9 as a prognosticator correlated with lipid metabolism in pancreatic adenocarcinoma. Zhou S; Guo Q; Chen A; Li X; Zou X World J Surg Oncol; 2024 Sep; 22(1):256. PubMed ID: 39342295 [TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA SNHG17 contributes to the progression of pancreatic adenocarcinoma by modulating miR-32-5p/EZH2/STAT3 signaling. Ying L; Wang J; Feng J; Wu Z Mol Biol Rep; 2023 Jul; 50(7):5941-5947. PubMed ID: 37253918 [TBL] [Abstract][Full Text] [Related]
13. Single-cell sequencing combined with spatial transcriptomics reveals that the IRF7 gene in M1 macrophages inhibits the occurrence of pancreatic cancer by regulating lipid metabolism-related mechanisms. Zhan T; Zou Y; Han Z; Tian X; Chen M; Liu J; Yang X; Zhu Q; Liu M; Chen W; Chen M; Huang X; Tan J; Liu W; Tian X Clin Transl Med; 2024 Aug; 14(8):e1799. PubMed ID: 39118300 [TBL] [Abstract][Full Text] [Related]
14. PLAGL1 is associated with prognosis and cell proliferation in pancreatic adenocarcinoma. Liang X; Fu Z; Tang L; Zheng M; Chen D; Liu A; Shi L; Yang L; Shao C; Dong X BMC Gastroenterol; 2023 Jan; 23(1):2. PubMed ID: 36600208 [TBL] [Abstract][Full Text] [Related]
15. tRNA-derived RNA fragment, tRF-18-8R6546D2, promotes pancreatic adenocarcinoma progression by directly targeting ASCL2. Lan S; Liu S; Wang K; Chen W; Zheng D; Zhuang Y; Zhang S Gene; 2024 Nov; 927():148739. PubMed ID: 38955307 [TBL] [Abstract][Full Text] [Related]
16. CSN6 inhibition suppresses pancreatic adenocarcinoma metastasis via destabilizing the c-Fos protein. Ma F; Wang H; Liu K; Wang Z; Chen S Exp Cell Res; 2020 Jun; 391(1):112004. PubMed ID: 32289284 [TBL] [Abstract][Full Text] [Related]
17. SPDEF drives pancreatic adenocarcinoma progression via transcriptional upregulation of Jiang H; Xue Z; Zhao L; Wang B; Wang C; Song H; Sun J Biomol Biomed; 2024 Sep; 24(5):1231-1243. PubMed ID: 38520747 [TBL] [Abstract][Full Text] [Related]
18. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma. You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X Front Immunol; 2022; 13():864244. PubMed ID: 35720314 [TBL] [Abstract][Full Text] [Related]
19. COL10A1 promotes tumorigenesis by modulating CD276 in pancreatic adenocarcinoma. Xu Q; Zheng J; Su Z; Chen B; Gu S BMC Gastroenterol; 2023 Nov; 23(1):397. PubMed ID: 37974070 [TBL] [Abstract][Full Text] [Related]
20. Ginsenoside Rg3 suppresses vasculogenic mimicry by impairing DVL3-maintained stemness via PAAD cell-derived exosomal miR-204 in pancreatic adenocarcinoma. Cai X; Wang Z; Lin S; Chen H; Bu H Phytomedicine; 2024 Apr; 126():155402. PubMed ID: 38350242 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]